Group 1 - Eddie Pharmaceuticals (688488.SH) reported its Q1 2025 results on April 30, 2025, with 15 institutional investors holding a total of 226 million shares, representing 53.78% of the company's total equity [1] - The top ten institutional investors collectively hold 52.67% of the shares, with a decrease of 1.14 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, four funds reduced their holdings compared to the previous quarter, with a total decrease of 0.91% [2] - One new public fund disclosed its holdings during this period, namely Hongtu Innovation Healthcare Stock [2] - A total of 93 public funds did not disclose their holdings this quarter, including several notable funds such as GF Healthcare Stock A and Bank of China Healthcare Mixed A [2]
机构风向标 | 艾迪药业(688488)2025年一季度已披露前十大机构持股比例合计下跌1.14个百分点